SIRT3 and Parkinson disease: Notably, this study identifies a novel mechanism involving aberrant SIRT3‐mediated DRP1 acetylation at K711 as a key driver of mitochondrial dysfunction and DA neuronal death in PD, revealing a potential target for PD treatment.